Keyphrases
Prostate Cancer
100%
MicroRNA
40%
Hypoxia
33%
DNA Damage
20%
Alkaline Comet Assay
18%
Prostate Tumor
17%
Androgen Deprivation Therapy
17%
Prostate Cancer Cells
16%
Bicalutamide
15%
MiR-200c
15%
MicroRNA-21 (miR-21)
15%
Gene Expression
15%
Methylation
14%
Bladder Cancer Cells
14%
Hypoxia-activated Prodrug
14%
Comet Assay
11%
Urinary Bladder
11%
Tumor
10%
Premature Cardiovascular Disease
10%
Malignant Progression
10%
MiR-24
10%
Blood Pressure
9%
LNCaP
9%
P27 Expression
9%
Meta-analysis
9%
Serum Markers
9%
Radiosensitivity
9%
Mitomycin C
9%
Cav1.3
9%
Serum Levels
8%
Methylenetetrahydrofolate Reductase (MTHFR)
8%
Apoptosis
8%
Nuclear Chromatin
7%
Bladder Carcinoma Cells
7%
Carcinoma Cell Lines
7%
Epigenetic Regulation
7%
Tumor Hypoxia
7%
Chromatin
6%
DNA Repair
6%
Androgen Insensitivity Syndrome
6%
Prostate Cancer Cell Lines
6%
Castration-resistant
6%
Radiosensitive
6%
DNA Interstrand Crosslinks
6%
Tumor Growth
6%
MicroRNA Expression
5%
Gene-rich Regions
5%
TP53 Gene
5%
Personalized Medicine
5%
Store-operated Calcium
5%
Medicine and Dentistry
Prostate Cancer
19%
Chromatin
9%
Bladder Cell Line
9%
microRNA 24
9%
microRNA
8%
Cells
8%
Tumor Hypoxia
6%
Disease
6%
Serum
6%
Personalized Medicine
5%
CDKN1B
5%